News

Saultz and Lochner’s research have long highlighted how relational continuity enhances trust, communication, and shared ...
The FDA has a new director for the Center for Drug Evaluation and Research (CDER), with biopharma industry executive George ...
The new approval will help Merck make a return on its $3.9 billion investment in acquiring SpringWorks, which has operated as ...
AstraZeneca has bolstered the standing of Tagrisso as a first-line treatment for locally advanced or metastatic EGFR-mutated ...
On day three of BIO 2025, editor-in-chief Jonah Comstock caught up with OS Therapeutics CEO Paul Romness and EVERSANA VP of ...
A once-daily tablet that can help people suffering from hay fever caused by birch tree pollen, Alk-Abelló's Itulazax, has ...
Sarepta has refused to suspend all dosing of its gene therapy for Duchenne muscular dystrophy, Elevidys, defying a clinical ...
"While COPD remains the third leading cause of death worldwide, patients and families have limited treatment options for ...